199 related articles for article (PubMed ID: 8477194)
21. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
[TBL] [Abstract][Full Text] [Related]
22. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE
Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938
[TBL] [Abstract][Full Text] [Related]
23. Dolastatin 10 and dolastatin 15: effects of two natural peptides on growth and differentiation of leukemia cells.
Steube KG; Grunicke D; Pietsch T; Gignac SM; Pettit GR; Drexler HG
Leukemia; 1992 Oct; 6(10):1048-53. PubMed ID: 1405759
[TBL] [Abstract][Full Text] [Related]
24. The effect of bryostatin 1 on human lymphocyte-mediated cytotoxicity.
Tilden AB; Kraft AS
J Immunother (1991); 1991 Apr; 10(2):96-104. PubMed ID: 1828367
[TBL] [Abstract][Full Text] [Related]
25. Two protein kinase C activators, bryostatin-1 and phorbol-12-myristate-13-acetate, have different effects on haemopoietic cell proliferation and differentiation.
Ng SB; Guy GR
Cell Signal; 1992 Jul; 4(4):405-16. PubMed ID: 1419483
[TBL] [Abstract][Full Text] [Related]
26. Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line Reh.
Wall NR; Mohammad RM; Al-Katib AM
Cell Growth Differ; 2001 Dec; 12(12):641-7. PubMed ID: 11751459
[TBL] [Abstract][Full Text] [Related]
27. Bryostatin-1 enhances the maturation and antigen-presenting ability of murine and human dendritic cells.
Do Y; Hegde VL; Nagarkatti PS; Nagarkatti M
Cancer Res; 2004 Sep; 64(18):6756-65. PubMed ID: 15374994
[TBL] [Abstract][Full Text] [Related]
28. The catalytic domain of protein kinase Cdelta confers protection from down-regulation induced by bryostatin 1.
Lorenzo PS; Bögi K; Acs P; Pettit GR; Blumberg PM
J Biol Chem; 1997 Dec; 272(52):33338-43. PubMed ID: 9407126
[TBL] [Abstract][Full Text] [Related]
29. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation.
Drexler HG; Gignac SM; Pettit GR; Hoffbrand AV
Eur J Immunol; 1990 Jan; 20(1):119-27. PubMed ID: 1689659
[TBL] [Abstract][Full Text] [Related]
30. The differentiation inducing effect of bryostatin 5 on human myeloid blast cells is potentiated by vitamin D3.
van der Hem KG; Dräger AM; Huijgens PC; Tol C; Devillé W; Langenhuijsen MM
Leukemia; 1994 Feb; 8(2):266-73. PubMed ID: 7508534
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C.
Isakov N; Galron D; Mustelin T; Pettit GR; Altman A
J Immunol; 1993 Feb; 150(4):1195-204. PubMed ID: 8432975
[TBL] [Abstract][Full Text] [Related]
32. Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60.
Kraft AS; Smith JB; Berkow RL
Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1334-8. PubMed ID: 3456591
[TBL] [Abstract][Full Text] [Related]
33. Differentiating agents do not induce a true hairy cell phenotype in B-CLL cells in vitro.
Gartenhaus R; Hoffman M; Fuchs A; Billet H; Wang P; Gentile P; Rai K
Leuk Lymphoma; 1996 Jun; 22(1-2):97-101, follow.186, color plate IX. PubMed ID: 8724534
[TBL] [Abstract][Full Text] [Related]
34. Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells.
Rao AS; Freemerman AJ; Jarvis WD; Chelliah J; Bear HD; Mikkelsen R; Grant S
Leukemia; 1996 Jul; 10(7):1150-8. PubMed ID: 8683995
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of leukemic cell growth by the protein kinase C activator bryostatin 1 correlates with the dephosphorylation of cyclin-dependent kinase 2.
Asiedu C; Biggs J; Lilly M; Kraft AS
Cancer Res; 1995 Sep; 55(17):3716-20. PubMed ID: 7641182
[TBL] [Abstract][Full Text] [Related]
36. Dephosphorylation of activated protein kinase C contributes to downregulation by bryostatin.
Lee HW; Smith L; Pettit GR; Bingham Smith J
Am J Physiol; 1996 Jul; 271(1 Pt 1):C304-11. PubMed ID: 8760059
[TBL] [Abstract][Full Text] [Related]
37. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.
Basu A; Lazo JS
Cancer Res; 1992 Jun; 52(11):3119-24. PubMed ID: 1591725
[TBL] [Abstract][Full Text] [Related]
38. Differing modulation of protein kinase C by bryostatin 1 and phorbol esters in JB6 mouse epidermal cells.
Kraft AS; Reeves JA; Ashendel CL
J Biol Chem; 1988 Jun; 263(17):8437-42. PubMed ID: 3286649
[TBL] [Abstract][Full Text] [Related]
39. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60).
Kraft AS; Baker VV; May WS
Oncogene; 1987 May; 1(2):111-8. PubMed ID: 3325877
[TBL] [Abstract][Full Text] [Related]
40. Primary acute myeloid leukaemia blasts resistant to cytokine-induced differentiation to dendritic-like leukaemia cells can be forced to differentiate by the addition of bryostatin-1.
Roddie PH; Horton Y; Turner ML
Leukemia; 2002 Jan; 16(1):84-93. PubMed ID: 11840267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
